Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mangiola

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Annals of Neurology|June 9, 1999
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotypeE Ricci, G Galluzzi, G Deidda, et al.
Beneficial Microbes|September 5, 2020
Increased <i>Faecalibacterium</i> abundance is associated with clinical improvement in patients receiving rifaximin treatmentF R Ponziani, F Scaldaferri, M De Siena, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 25, 2009
Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variablesP Cudia, P Bernasconi, R Chiodelli, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Annals of Neurology|June 9, 1999
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotypeE Ricci, G Galluzzi, G Deidda, et al.
Beneficial Microbes|September 5, 2020
Increased <i>Faecalibacterium</i> abundance is associated with clinical improvement in patients receiving rifaximin treatmentF R Ponziani, F Scaldaferri, M De Siena, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 25, 2009
Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variablesP Cudia, P Bernasconi, R Chiodelli, et al.
Pageof 2